Announcements Trials
Browse Landscape

Phase

Phase 3 3

Status

Completed 3

Sponsor Class

OTHER 8NIH 3NETWORK 3

Study Type

Interventional 3

Sponsor

Cancer Type

Other neoplasm 3Genitourinary 3Thoracic 1Gastrointestinal 1

Conditions

Prostatic Neoplasms 3Precancerous Conditions 2

Interventions

Radiotherapy 34Gemcitabine 24Docetaxel 24bicalutamide 23Goserelin 21Paclitaxel 19Cisplatin 19Doxorubicin 18Carboplatin 18Flutamide 17Leuprolide 16Radiotherapy, Conformal 13Etoposide 13Filgrastim 12Prednisone 11Gene Expression Profiling 11Gonadotropin-Releasing Hormone 10Radiotherapy, Intensity-Modulated 9Vincristine 8Vinblastine 8Triptorelin Pamoate 8Magnetic Resonance Spectroscopy 8Cyclophosphamide 8Buserelin 8Androgen Antagonists 8Surgical Procedures, Operative 7Radiation 7Polymerase Chain Reaction 7Methotrexate 7Estramustine 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
NETWORK × Selenium × Genitourinary × Clear all
NCT00064194 2020-04-03

Vitamin E, Selenium, and Soy Protein in Preventing Cancer in Patients With High-Grade Prostate Neoplasia

Canadian Cancer Trials Group

Phase 3 Completed
310 enrolled
GenitourinaryOther neoplasm

Precancerous Conditions, Prostatic Neoplasms

NCT00006392 2015-11-20

SELECT

SWOG Cancer Research Network

Phase 3 Completed
35,533 enrolled 20 charts
Genitourinary

Prostatic Neoplasms

NCT00030901 2013-02-06

S9917, Selenium in Preventing Cancer in Patients With Neoplasia of the Prostate

SWOG Cancer Research Network

Phase 3 Completed
619 enrolled 11 charts
GenitourinaryOther neoplasm

Precancerous Conditions, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡